Compare LINK & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LINK | ICCC |
|---|---|---|
| Founded | 1984 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 66.6M | 55.5M |
| IPO Year | N/A | 1987 |
| Metric | LINK | ICCC |
|---|---|---|
| Price | $3.85 | $6.12 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $8.67 | N/A |
| AVG Volume (30 Days) | ★ 50.6K | 31.6K |
| Earning Date | 11-12-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.26 |
| Revenue | $12,023,000.00 | ★ $27,769,304.00 |
| Revenue This Year | $8.30 | N/A |
| Revenue Next Year | $34.68 | N/A |
| P/E Ratio | ★ N/A | $23.71 |
| Revenue Growth | N/A | ★ 16.49 |
| 52 Week Low | $2.99 | $4.28 |
| 52 Week High | $10.10 | $7.60 |
| Indicator | LINK | ICCC |
|---|---|---|
| Relative Strength Index (RSI) | 45.93 | 57.72 |
| Support Level | $3.67 | $5.56 |
| Resistance Level | $4.06 | $6.19 |
| Average True Range (ATR) | 0.33 | 0.35 |
| MACD | 0.18 | 0.02 |
| Stochastic Oscillator | 70.38 | 38.68 |
Interlink Electronics Inc is a sensor and printed electronics company operating in two principal sensor technology divisions: force/touch sensors, and gas and environmental sensors. It designs, develops, manufactures and sells a range of force-sensing and gas-sensing technologies that incorporate its proprietary materials technology, firmware and software into a portfolio of standard sensor-based products and custom sensor system solutions. Its force-sensing products and solutions include sensor components, subassemblies, modules products that support effective, efficient cursor control and novel three-dimensional user inputs. Its Human Machine Interface technology platforms are deployed in a wide range of markets including consumer electronics, automotive, industrial, and medical.
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.